Can above-optimal glucose, elevated triglycerides, and low HDL cholesterol promote inflammation and HPA-axis activation?

The coexistence of above-optimal glucose, elevated triglycerides, and low high-density lipoprotein (HDL) cholesterol creates a highly integrated metabolic stress state. This pattern actively promotes systemic inflammation and endocrine disruption through tightly coupled, self-reinforcing feedforward loops.

Inflammatory signaling mechanisms

• Glucotoxicity and lipotoxicity: Above-optimal glucose levels drive the accumulation of reactive oxygen species (ROS) and advanced glycation end products (AGEs), activating vascular nuclear factor kappa B (NF-κB) pathways.
• Cytokine escalation: Elevated triglycerides and circulating free fatty acids act as ligands for Toll-like receptor 4 (TLR4) on macrophages and adipose tissue. This synergizes with glucotoxic pathways to increase transcription of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β), elevating clinical markers like high-sensitivity C-reactive protein (hs-CRP).

Bidirectional HPA-axis activation

• Neuroendocrine stimulation: Chronic glycemic fluctuations and hyperinsulinemia serve as physical stressors that stimulate hypothalamic corticotropin-releasing hormone (CRH) production. Concurrently, peripheral cytokines (IL-6 and TNF-α) cross the blood-brain barrier to directly activate the hypothalamic-pituitary-adrenal (HPA) axis, leading to functional hypercortisolism.
• Self-reinforcing feedback: Elevated cortisol levels further drive metabolic dysfunction by upregulating hepatic gluconeogenesis, impairing peripheral glucose uptake, and promoting lipolysis. This releases additional free fatty acids that are re-esterified into triglycerides, reinforcing the initial dyslipidemic and dysglycemic triad.

Bottom line

• The triad of above-optimal glucose, elevated triglycerides, and low HDL operates as a unified metabolic stressor that stimulates chronic inflammatory signaling and HPA-axis activation, establishing a self-perpetuating loop of endocrine and cardiovascular risk.